November 23, 2020

Significant biosimilar activities this week include:

  • 15 Nov 20, US: Genentech filed a complaint against Centus Biotherapeutics, Fujifilm Kyowa Kirin Biologics, Fujifilm Corp and Kyowa Kirin in the Eastern District of Texas, relating to 10 Genentech licensed or owned...

Significant biosimilar activities this week include:

  • 28 Sep 20: Innovent announced its ph III trial of Byvasda® (proposed bevacizumab biosimilar) in combination with Tyvyt® (sintilimab) met its primary endpoints of progression-free survival and overall survival.  In...

Significant biosimilar activities this week include:

  • 20 Jul 20, EU: Spherix reported that the EU market for AbbVie's Humira® has been negatively impacted by gastroenterologists increasingly prescribing alternative mechanism of action agents, including Stelara® (uste...

Please reload

Biosimilars bulletin 

November 9, 2020

Please reload

Search by tags